(877) 505-4777| info@speakersnetwork.com

Infectious Diseases

Medical Director, Healthcare Epidemiology, Infection Prevention and Control
Professor of Medicine, Division of Infectious Diseases

Antimicrobial Therapy Update: New Drugs for Resistant Bugs
Enhancing Patient Safety by the Prevention and Control of Healthcare-Associated Infections
Antimicrobial Resistance: From the Farm to the Bedside
Resistant Gram-Positive Infections: Focus on MRSA and CA-MRSA
Pandemic, Avian, and Seasonal Influenza
Pneumonia: Making Sense of the Guidelines
Bloodborne Pathogens: What the Healthcare Worker Should Know
Sepsis: Pathogens, Pathogenesis, and Treatment
Complicated Skin Infections: Prevention and Management
Clostridium Difficile Infection
SuperBugs: Virulence and Resistance Mechanism in Gram Negative Bacteria
Prevention of Management of CAUTI

He is a fantastic speaker. – Parkview Medical Center I am so very happy you were able to schedule this speaker for one of our November dates. He is the very best speaker and I don’t know what I will do without him being available in the future. We’ve used him often and he always receives excellent reviews. The Univ. of Penn. is very lucky to have him!! – Torrance Memorial Medical Center
PA

Chief, Infectious Disease Service
Associate Professor of Clinical Medicine

Perilous Pets: Modern Zoonoses / Pet Associated Infection
Infectious Disease Update: Legionnaire’s Disease, Chikungunya, West Nile Virus etc.
Time Out for Ticks: Tick-borne Disease in Los Angeles
Trouble in Paradise: Travel Medicine Update
Ebola Viral Infection: What Doctors and Hospitals Need to Know
ID Dermal Dilemmas: Antibiotic-Associated Skin Rash
Bugs and Drugs: Antibiotic Therapy 2016
Central Nervous System Infections Including West Nile Virus
Infections of Mexico and Central America
Malaria: Pearls and Pitfalls for the Houseofficer
Antibiotic Resistance
Parasitic Infections in HIV+ Patients
History of Penicillin: Lessons for the Houseofficer

Good at-ease speaker with light humorous touch- Providence Holy Cross Medical Center
CA

Associate Chief, Adult Infectious Diseases
Senior Investigator
Vice Chair, Academic Affairs
LA Biomedical Research Institute
Professor of Medicine
David Geffen School of Medicine at UCLA

Infective Endocarditis
Prophylaxis of Endocarditis

In a faculty career spanning more than 30 years, Dr. Arnold Bayer has dedicated himself to deepening our understanding of infectious disease. He continues to study the ways in which the human body responds to infection and builds up resistance to antibiotics, with an ultimate goal of developing strategies for effectively fighting off pathogens. With funding from both NIH/NIAID and private sector pharmaceutical sources, Dr. Bayer is conducting research related to the mechanisms by which platelet peptides kill common blood stream pathogens, as well as to the study of the genetic mechanisms by which certain strains of bacteria develop resistance and cross-resistance to antibiotics. In addition to his numerous responsibilities within the Harbor-UCLA Medical Center community, Dr. Bayer plays an active role in the international medical and academic spheres. A co-author of well over 200 scientific papers, book chapters and major reviews and a frequent lecturer and presenter on topics concerning infectious disease, Dr. Bayer has served on national committees, including the National American Heart Associations Committee on Rheumatic Fever, Endocarditis & Kawasakis Disease; NIAIDs National Association for Research in Staphylococcus aureus (NARSA); and, the International Society on Cardiovascular Infectious Diseases (ISCVID). He is a charter committee member of the International Consortium for the Study of Infective Endocarditis (ICE) and he also serves as ongoing principal investigator and steering committee member for the Consortiums UCLA site. Dr. Bayer began his medical education on the East coast, earning his degree from Temple University School of Medicine in Philadelphia, Pennsylvania. After completing an internship and junior residency program at Thomas Jefferson University Hospital, also in Philadelphia, Dr. Bayer came to Harbor-UCLA Medical Center as a senior resident in Internal Medicine, and a Clinical-Research Fellow in infectious diseases. Immediately thereafter, he began post-doctoral research fellowship in infectious diseases at Wadsworth VA Medical Center in Los Angeles, CA, before joining the faculty at Harbor-UCLA and LA Biomed.
CA

Vice Chair, Quality Improvement
Professor of Medicine
Hospital Epidemiologist and Director of Infection Control
Medical University of South Carolina

Hospital Epidemiology
Infection Control
Antibiotic Resistance
HIV Care

sc

Assistant Professor of Medicine

Tuberculosis
Vaccines
Adult Vaccinations
HIV
Current Concepts in Varicella Zoster Disease-Prevention and Treatment
Ebola Virus: Clinical Manifestations and Infection Control

TX

Professor of Medicine
Division of Infectious Diseases

Super Bugs
Update on Infections of the Central Nervous System
Visual Diagnosis of Infectious Diseases
Dermatologic Manifestations of Infectious Diseases
Lyme Disease, Anthrax, Staphylococcal Infections, Streptococcal Infections
Tick Associated Infections
Update on Fungal Infections
Ophthalmological Infections: Changing Patterns with AIDS
Update: ENT Infections
Osteomyelitis, Septic Arthritis, Mycetoma
Infectious Endocarditis, Pericarditis, Myocarditis
Changing Concepts of Gastrointestinal Diseases
Intra-Abdominal Infections
Anaerobic Infections
Update : Septic Shock Diagnosis and Management
Acquired Immunodeficiency Syndrome (HIV/AIDS)
Zoonosis Update
Infections in Travelers and Immigrants
Respiratory Airway Infections
What’s New in Infectious Diseases
Mosquito Borne Infections
Ebola – An Emerging Threat?
Ebola Update
Ebola? A Pandemic in the Making
Surgical Site Infections
Zika Virus

He was excellent. One of the best lectures we had all year. Richmond University Medical Center Staten Island. Everyone loved him! Richmond University Medical Center He was very informative and very very nice man- CentraState Medical Center The programs was excellent. This faculty speaker was a superb lecturer. We would love to have him back.- Memorial Hospital Maine Health
NJ

Assistant Professor of Medicine

How to Change Prescribing to Protect Your Patients From Clostridium Difficile
How to Change Prescribing to Bring Antibiotic Resistance Under Control
Simple Strategies to Reduce MRSA Related Readmissions
Cutting Edge Initiatives in LA and Orange County to Reduce Antibiotic Resistance
Cutting Edge of Decolonization for MRSA and Other Multi-Drug Resistant Organisms (MDRO)
Sharing Patients from the “Outside Hospital” and Understanding Infection Control
Antimicrobial Stewardship after Hospital Discharge; Why the Hospital and Skilled Nursing Facility Should Care
Understanding How to Implement Decolonization in Your Hospital; From the ICU, to the Floor, to the Post-Discharge Period
The PROTECT Series and SHIELD-OC, the Arrival of Public Health in the Fight for Antimicrobial Resistance

Very good speaker! – Providence Holy Cross Medical Center
CA

Professor of Medicine
Division of Emergency Medicine and Infectious Diseases

Pandemic Influenza Preparedness
Biological Terrorism: Are You Prepared?
Antibiotic Update: Treatment of Common Infections
Whats Pneu in Pneumonia
Treatment of URIs and Bronchitis – What Works; What Doesnt
AIDS Emergencies
Sexually Transmitted Diseases
Meningitis
Management of Needlesticks and Body Fluid Exposures
Antibiotic-Resistant Organisms: How Can We Treat Them?
Intra-Abdominal Infections
Fights, Bites, and Flesh-Eating Frights: Serious Skin & Soft Tissue Infections
Infectious Diseases in the Emergency Department
Rabies
Tuberculosis
Urine Trouble: Whats New in Urinary Tract Infections
Emerging Infectious Diseases: Whats New in the “Hot Zone”
Necrotizing Fasciitis
Alternative Medicines for Common Infections
Small Pox
Community-Associated MRSA: The New Epidemic

CA

Director, RM Alden Research Laboratory
Clinical Editor, Clinical Infectious Diseases
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA

Antibiotic Stewardship
Proper Use of Carbapenems in the Era of Resistance
C Difficile
Probiotics and Diarrhea
Complicated UTIs
Pneumonia
Anaerobic Infections
New Drugs
Skin and Soft Tissue Infections: The Times They Are Achanging

CA

Professor, Division of Infectious Diseases
Departments of Internal Medicine and Microbiology
Director, Levitt Center for Viral Pathogenesis
University of Iowa

HIV / AIDS Update for the PCP
Hepatitis C

IA